Annual Report

Overview

The report presents the Group's seventh ESG report for the 2021/22 Reporting Period, covering its pharmaceutical wholesale and distribution and hemodialysis treatment and consultancy businesses. The company describes Board-led ESG oversight, including assessment and management of material ESG risks. It reports 670.08 Tonnes CO2 equivalent of total greenhouse gas emissions, comprising Scope 1 and Scope 2, alongside total energy consumption of 1,192.27 MWh.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 April 2021 – 31 March 2022
Language: English, Chinese
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services